butabarbital decreases results of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of CYP3A4 inducers may well decrease sufentanil levels and efficacy, maybe precipitating withdrawal syndrome in people who may have created Bodil